Evidence map›Paper›PMID 40929233›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2025

Cardiac myosin-binding protein-C acts as a tunable load sensor to regulate afterload dependence of ventricular function.

Laurin M Hanft, Theodore J Kalogeris, Daniel J Davis, Mei Methawasin, Kerry S McDonald

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laurin M HanftDepartment of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, Missouri, United States.
Theodore J KalogerisDepartment of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, Missouri, United States.
Daniel J DavisDepartment of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, United States.
Mei MethawasinDepartment of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, Missouri, United States.
Kerry S McDonaldDepartment of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, Missouri, United States.ORCID 0000-0002-1588-1782

Funding

Dual filament control of myocardial power and hemodynamicsR01HL148785 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI Kenneth S Campbell, Thomas Kampourakis · 2020 to 2026
$3.2M
Sex-specific myofilament dysfunction in postmenopausal HFpEFR01HL171047 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI Mei Methawasin · 2024 to 2026
$1.3M
HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) HL148785NHLBI NIH HHS R01 HL148785NHLBI NIH HHS R01 HL171047
6 · The paper itself

Abstract

The sarcomeric protein cardiac myosin-binding protein-C (cMyBP-C) binds myosin on thick filaments and regulates cardiac myocyte contraction. Our lab has reported that permeabilized cardiac myocytes lacking cMyBP-C generate greater power and show disproportionately fast sarcomere shortening velocities at high loads. Also, high-resolution X-ray diffraction of cardiac trabeculae found that myosin cross bridges in the cMyBP-C zone are the most active during loaded contractions. Together, these results implicate cMyBP-C as a potential molecular load sensor. We tested the hypothesis that cMyBP-C is a tunable load sensor that matches afterload and left ventricular (LV) performance. We compared the afterload dependence of LV power between isolated hearts from mice lacking cMyBP-C knockout (KO) or transgenic mice expressing either wild-type (cMyBP-C WT), cMyBP-C carrying pseudo-phosphorylated cMyBP-C (cMyBP-C t3SD), or nonphosphorylatable cMyBP-C (cMyBP-C t3SA). cMyBP-C KO hearts exhibited minimal differences in LV power as a function of afterload from 40 to 60 mmHg. In contrast, cMyBP-C WT hearts exhibited relatively steep afterload dependence of LV power. We also tested whether load sensing is tunable by cMyBP-C phosphorylation. We observed steep afterload dependence of LV power in hearts carrying pseudo-phosphorylated cMyBP-C (cMyBP-C t3SD). Alternatively, hearts with nonphosphorylatable cMyBP-C (cMyBP-C t3SA) exhibited less afterload dependence of LV power. Thus, it appears cMyBP-C acts as a tunable load sensor that matches myofilament power with hemodynamics.

Indexed as

Carrier ProteinsMyocardial ContractionMyocytes, CardiacVentricular Function, LeftAnimalsMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMyosin Binding Protein CPhosphorylationSarcomeresCarrier ProteinsMyosin Binding Protein Cafterloadcardiacisolated working heartsleft ventricular powermyosin-binding protein-C

Identifiers

PMID40929233
PMCPMC12478523

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.